IOL Chemicals Q4 results show strong revenue and profit growth
after close1 source ↓written by the desknot a recommendation
- following the release
- 9%
- YoY
- 69.2%
- to ₹92.5 cr
- 47.3%
- margins expanding
- 14.9%
Shares of IOL Chemicals and Pharmaceuticals rose 9% following the release of its Q4 earnings. The company reported a net profit of ₹53.2 cr, up 69.2% YoY, while revenue increased 17.4% to ₹620 cr. EBITDA surged 47.3% to ₹92.5 cr, with margins expanding to 14.9%. This strong performance may enhance investor sentiment.
Not investment advice. For informational purposes only.